We are live on ! Find out more
EPIX

ESSA Pharma
EPIX

Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

8 hedge funds and large institutions have $8.04M invested in ESSA Pharma in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.06% more ownership

Funds ownership: 66.18% → 66.24% (+0.06%)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

30% less capital invested

Capital invested by funds: $11.5M → $8.04M (-$3.49M)

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$4.89M
2
BI
BVF Inc
California
+$10.5K
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$15

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$469

EPIX Hedge Fund Activity: Q4 2018 in Review

8 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q4 2018, worth a combined $8.04M — down 30% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EPIX positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Blackstone Inc, opening a new position worth an estimated $4.89M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.

  • 8 institutional investors held ESSA Pharma (EPIX) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $8.04M of ESSA Pharma stock for Q4 2018, down 30% quarter-over-quarter.
  • 2 funds opened new ESSA Pharma positions in Q4 2018 and 1 closed out, a net change of +1 holder.
  • The largest ESSA Pharma buyer in Q4 2018 was Blackstone Inc, an estimated $4.89M added.
  • The largest ESSA Pharma seller in Q4 2018 was Tower Research Capital (TRC), an estimated $1K sold.

Based on aggregated 13F filings for Q4 2018.